Jeff Binder, CEO of ImmucorBinder actually led Biomet for 8 years before the June 2015 closing of its roughly $13 billion merger with Zimmer. A month later he took the top spot at Norcross, Ga.–based Immucor, a privately held provider of transfusion and transplantation diagnostic products.
Perhaps Binder might be interested in returning to Indiana? Wells Fargo analyst Larry Biegelsen thinks it’s a possibility.
When asked over LinkedIn, Binder said he didn’t have any comments on the matter.